Developing and Validating a Self-Care Self-Efficacy Scale for Oral Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Protocol for a Mixed Methods Study
JMIR Research Protocols · 2024
DOI: 10.2196/51489 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Arianna Magon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Self Care, Self Efficacy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Oral anticoagulation therapy (OAC) is the cornerstone treatment for preventing venous thromboembolism and stroke in patients with nonvalvular atrial fibrillation (NVAF). Despite its significance, challenges in adherence and persistence to OAC regimens have been reported, leading to severe health complications. Central to addressing these challenges is the concept of self-efficacy (SE) in medication management. Currently, there is a noticeable gap in available tools specifically designed to measure SE in OAC self-care management, while such tools are crucial for enhancing patient adherence and overall treatment outcomes.
Objective
This study aims to develop and validate a novel scale aimed to measure self-care self-efficacy (SCSE) in patients with NVAF under OAC, which is the patients’ Self-Care Self-Efficacy Index in Oral Anticoagulation Therapy Management (SCSE-OAC), for English- and Italian-speaking populations. We also seek to assess patients’ SE in managing their OAC treatment effectively and to explore the relationship between SE levels and sociodemographic and clinical variables.
Methods
Using a multiphase, mixed methods observational study design, we first conceptualize the SCSE-OAC through literature reviews, patient focus groups, and expert consensus. The scale’s content validity will be evaluated through patient and expert reviews, while its construct validity is assessed using exploratory and confirmatory factor analyses, ensuring cross-cultural applicability. Criterion validity will be examined through correlations with clinical outcomes. Reliability will be tested via internal consistency and test-retest reliability measures. The study will involve adult outpatients with NVAF on OAC treatment for a minimum of 3 months, using both e-surveys and paper forms for data collection.
Results
It is anticipated that the SCSE-OAC will emerge as a reliable and valid tool for measuring SE in OAC self-care management. It will enable identifying patients at risk of poor adherence due to low SE, facilitating targeted educational interventions. The scale’s validation in both English and Italian-speaking populations will underscore its applicability in diverse clinical settings, contributing significantly to personalized patient-centered care in anticoagulation management.
Conclusions
The development and validation of the SCSE-OAC represent a significant advancement in the field of anticoagulation therapy. Validating the index in English- and Italian-speaking populations will enable personalized patient-centered educational interventions, ultimately improving OAC treatment outcomes. The SCSE-OAC’s focus on SCSE introduces a novel approach to identifying and addressing individual patient needs, promoting adherence, and ultimately improving health outcomes. Future endeavors will seek to extend the validation of the SCSE-OAC across diverse cultural and linguistic landscapes, broadening its applicability in global clinical and research settings. This scale-up effort is crucial for establishing a universal standard for measuring SCSE in OAC management, empowering clinicians and researchers worldwide to tailor effective and culturally sensitive interventions. Trial Registration ClinicalTrials.gov NCT05820854; https://tinyurl.com/2mmypey7 International Registered Report Identifier (IRRID) PRR1-10.2196/51489
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
- Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
- Centre for Heart Rhythm Disorders, The University of Adelaide and the Royal Adelaide Hospital, Adelaide, Australia.
- Clinical Research Service, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
- Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
ORCID-Profile: Arianna Magon, Jeroen Hendriks, Rosario Caruso
Zitieren
APA
Magon, A., Hendriks, J., & Caruso, R. (2024). Developing and Validating a Self-Care Self-Efficacy Scale for Oral Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Protocol for a Mixed Methods Study. JMIR Research Protocols. https://doi.org/10.2196/51489
Vancouver
Magon A, Hendriks J, Caruso R. Developing and Validating a Self-Care Self-Efficacy Scale for Oral Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Protocol for a Mixed Methods Study. JMIR Research Protocols. 2024. doi:10.2196/51489
BibTeX
@article{Magon2024,
author = {Magon, Arianna and Hendriks, Jeroen and Caruso, Rosario},
title = {Developing and Validating a Self-Care Self-Efficacy Scale for Oral Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Protocol for a Mixed Methods Study},
journal = {JMIR Research Protocols},
year = {2024},
doi = {10.2196/51489}
}
EUVIMED